Botulax 300

Botulax 300 – High-Capacity Botulinum Toxin for Clinical Efficiency and Versatile Application

1. Product Overview & Manufacturer
Botulax 300 is a botulinum toxin type A developed and manufactured by Hugel, Inc., one of South Korea’s leading biopharmaceutical companies. Hugel is globally recognized for its high standards of safety, innovation, and clinical performance in aesthetic medicine.
Botulax 300 is the high-unit version in the Botulax line, offering 300 units per vial for efficient use in clinics with high patient turnover or multi-area treatments.

2. Composition & Packaging

• Contains 300 units of purified botulinum toxin type A (Clostridium botulinum toxin) in lyophilized powder form.

• Requires reconstitution with sterile saline (0.9% NaCl) prior to injection.

3. Mechanism of Action
Like other botulinum toxins, Botulax 300 works by blocking the release of acetylcholine at the neuromuscular junction. This temporarily inhibits muscle contractions, resulting in:

• Relaxation of overactive or hypercontracted muscles

• Smoothing of dynamic wrinkles

• Suppression of excessive sweating (hyperhidrosis)

• Relief in therapeutic conditions involving muscle spasticity or nerve hyperactivity

4. Clinical Advantages

• High-dose capacity (300U) enables:

  • Treatment of multiple facial or body areas in one session

  • More economical dosing for clinics with large-scale usage

• Rapid onset: Results usually begin to appear within 3–5 days

• Long-lasting effects: Typically 3–6 months, depending on the individual and treatment zone

• Stable formulation with low immunogenicity—less risk of resistance or antibody formation

• Offers precise diffusion and consistent efficacy, making it reliable for advanced injectors

5. Applications

• Aesthetic Treatments:

  • Horizontal forehead lines, glabellar frown lines, crow’s feet

  • Masseter reduction for V-line facial contouring

  • Chin dimpling, gummy smile correction

  • Neck rejuvenation and trapezius slimming

• Therapeutic Indications:

  • Hyperhidrosis (palmar, axillary, plantar)

  • Chronic migraine

  • Cervical dystonia

  • Muscle spasticity in limbs or facial regions

6. Regulatory & Quality Assurance

• Manufactured in compliance with KFDA, GMP, and ISO standards

• Widely used in Asia, South America, and Middle East markets

• Supported by clinical studies and proven safety data

7. Storage & Handling

• Store between 2–8°C

• Use the reconstituted solution within the time frame advised by the manufacturer

• Strictly for use by qualified medical professionals